Search

everythinglearnresearchcommunity

for

Search:↓

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

New psoriasis treatments are effective but come with side effects and risks.

Most patients experienced hirsutism again after stopping hormone treatment, indicating long-term treatment is needed to maintain results.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Oral betamethasone works faster than oral tofacitinib for hair regrowth in alopecia areata.

Posaconazole is a promising new treatment for toenail fungus.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Low-dose methotrexate effectively regrows hair in many alopecia areata patients but can cause some side effects.

Oral minipulse therapy with betamethasone effectively promotes hair regrowth in alopecia areata with fewer side effects.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

Sequential immunotherapy can effectively treat alopecia areata by managing inflammation and promoting hair regrowth.

rTMS may help treat trichotillomania in some patients.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Double pulse dose terbinafine effectively treats kerion type of tinea capitis.

Baricitinib is more effective than methotrexate for severe alopecia areata.

Weekly treatments increased hair density in men with androgenetic alopecia.

imTA and pulse therapy are effective for alopecia areata with manageable side effects, but relapse rates need improvement.

Retinoids and narrowband UVB phototherapy are effective for treating psoriasis and can reduce treatment time when used together.

Patients on mood stabilizers need regular health checks, but many aren't monitored properly.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

People often struggle to consistently use contraceptives and other medications, and long-acting options might be better for those who want to avoid daily doses.